TrianglePUBLICATIONS · 12506170
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2003 Jan 1
- First author
- Ohtsu A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Ohtsu A
- type
- Author
- name
- Shimada Y
- type
- Author
- name
- Shirao K
- type
- Author
- name
- Boku N
- type
- Author
- name
- Hyodo I
- type
- Author
- name
- Saito H
- type
- Author
- name
- Yamamichi N
- type
- Author
- name
- Miyata Y
- type
- Author
- name
- Ikeda N
- type
- Author
- name
- Yamamoto S
- type
- Author
- name
- Fukuda H
- type
- Author
- name
- Yoshida S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ohtsu A
- type
- Author
- name
- Shimada Y
- type
- Author
- name
- Shirao K
- type
- Author
- name
- Boku N
- type
- Author
- name
- Hyodo I
- type
- Author
- name
- Saito H
- type
- Author
- name
- Yamamichi N
- type
- Author
- name
- Miyata Y
- type
- Author
- name
- Ikeda N
- type
- Author
- name
- Yamamoto S
- type
- Author
- name
- Fukuda H
- type
- Author
- name
- Yoshida S
- type
- Author
- bibliography ids
- nci-bib-e1fec87a4d0bdafea70017b0
- book metadata
- content sha256
- 55dfc143d167e59c79f81da9256f8bb07ede5359c5a49c6394e01b1ea6795068
- document type
- citation
- dois
- 10.1200/JCO.2003.04.130
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12506170
- immutable id
- pubmed:12506170@55dfc143d167e59c79f81da9256f8bb07ede5359c5a49c6394e01b1ea6795068
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 54-9
- volume
- 21
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12506170
- provenance
- batch id
- 6646708a43dc2007bef0
- provider
- NCBI PubMed ESummary
- record sha256
- 679a93bc02f911fb77ec4c2cf6159bc0a25ff1b3ca3c3c46553c84c34013ca04
- response sha256
- 2e7ae6114dac3dd1eb0d8799c51ad362081554b4e07621e9ff80c0fb43c178c7
- retrieved at
- 2026-09-09T23:45:48.511831+00:00
- publication date
- display
- 2003 Jan 1
- precision
- day
- year
- 2003
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Preserved source evidence · Not medical advice